Ubs Group Ag Imv Inc. Transaction History

Ubs Group Ag

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$0.47 - $0.75 $4,291 - $6,848	-9,131 Reduced 84.16%	1,718 $1,000
Q2 2022 Aug 10, 2022	BUY	$0.56 - $1.45 $5,113 - $13,239	9,131 Added 531.49%	10,849 $7,000
Q1 2022 May 16, 2022	SELL	$1.07 - $1.5 $8,057 - $11,295	-7,530 Reduced 81.42%	1,718 $2,000
Q4 2021 Feb 14, 2022	BUY	$1.22 - $1.78 $9,186 - $13,403	7,530 Added 438.3%	9,248 $11,000
Q3 2021 Nov 15, 2021	SELL	$1.35 - $2.16 $1,368 - $2,190	-1,014 Reduced 37.12%	1,718 $3,000
Q2 2021 Aug 13, 2021	BUY	$2.12 - $3.24 $4,772 - $7,293	2,251 Added 467.98%	2,732 $6,000
Q1 2021 May 12, 2021	SELL	$2.92 - $4.41 $11,642 - $17,582	-3,987 Reduced 89.23%	481 $2,000
Q4 2020 Feb 11, 2021	SELL	$2.9 - $4.4 $28,483 - $43,216	-9,822 Reduced 68.73%	4,468 $14,000
Q3 2020 Nov 12, 2020	BUY	$2.87 - $5.95 $41,012 - $85,025	14,290 New	14,290 $63,000
Q2 2020 Jul 31, 2020	SELL	$1.52 - $3.63 $5,096 - $12,171	-3,353 Closed	0 $0
Q1 2020 May 01, 2020	SELL	$1.4 - $4.92 $2,800 - $9,840	-2,000 Reduced 37.36%	3,353 $6,000
Q4 2019 Feb 14, 2020	BUY	$2.15 - $3.1 $11,167 - $16,101	5,194 Added 3266.67%	5,353 $16,000
Q3 2019 Nov 14, 2019	SELL	$2.25 - $3.82 $10,887 - $18,484	-4,839 Reduced 96.82%	159 $0
Q2 2019 Aug 14, 2019	BUY	$2.75 - $4.5 $13,744 - $22,491	4,998 New	4,998 $15,000
Q4 2018 Feb 14, 2019	SELL	$4.93 - $6.34 $5,028 - $6,466	-1,020 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$4.65 - $5.94 $2,697 - $3,445	-580 Reduced 36.25%	1,020 $6,000
Q2 2018 Aug 14, 2018	BUY	$4.42 - $7.13 $7,072 - $11,408	1,600 New	1,600 $8,000

Ticker IMV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,452,200
Description
IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is P...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.